ABOUT THE PROGRAM
T-Hub, in partnership with Jubilant Biosys, presents MedTech innovation day, “Re-inventing Drug Discovery by Digitalisation & Novel Technologies”, a market access program for innovative startups seeking opportunities to scale up through corporate strategic partnerships. . This program is designed to cater to MedTech startups as well as Jubilant Biosys in terms of investment, scalability of customer base, deal flow, PoC and entering to new markets.
MedTech innovation day is a great platform to collaborate and to pitch your innovative product in front of the technology SMEs and senior leadership team of Jubilant Biosys, which is looking to disrupt through both external and as well as internal innovation and to expand in their emerging business.
FOCUS AREAS
AI/ ML enabled target Identification, target validation, Hit generation, Lead Optimization and Toxicity prediction.
In silico animal models, cell models, organ models, membrane models etc. Replace cumbersome “wet” assays with in silico assays
Data capturing/ analysis tools for IOT implemented R&D & from for advanced LIMS
WHAT'S IN IT FOR YOU?
Startups
- Pitching opportunity to Jubliant Biosys
- Speed scaling up opportunities with Jubliant Biosys
- Meet and Greet session with Various Influencers of Jubliant Biosys.
Jubliant Biosys
- Exploring external innovation & disruption
- Exploring innovative products through startups and possible co-creation opportunities
- Exploring Deal Flow opportunities.
AGENDA
REGISTRATION
WELCOME SPEECH
KEYNOTE ADDRESS
PANEL SESSION
STARTUP PITCHES
NETWORKING SESSION
PROGRAM TIMELINE
ABOUT T-HUB
ABOUT JUBILANT BIOSYS
Jubilant Biosys Ltd., a Jubilant Life Sciences family of companies, has R&D centers in India and business offices in Asia and North America. It provides comprehensive drug discovery services and Contract research services.
For more information, visit: https://www.jubilantbiosys.com
